• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/27

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

27 Cards in this Set

  • Front
  • Back
MOA of Acyclovir
Monophosphorylated by viral thymidine kinase

Inhibits viral DNA polymerase

When incorporated into DNA it acts as a chain terminator
-lacks the equivalent of ribosyl 3' OH group
Mechanism of resistance of acyclovir
Lack of thymidine kinase
Clinical use of Acyclovir
HSV
VZV

Reduces viral shedding in HSV
Side effects of Acyclovir
Crystalluria (maintain full hydration)

NOT hematotoxic
Clinical use of Ganciclovir
HSV
VZV
**CMV**
Side effects of Ganciclovir
Hematotoxicity
Crystalluria (maintain hydration)
MOA of Ganciclovir
Needs phosphorylated by viral thymidine kinase

Inhibits viral DNA polymerase

Causes chain termination
MOA of Foscarnet
NOT A PRODRUG
-doesn't need phosphorylated

Inhibits DNA and RNA polymerases
Clinical use of Foscarnet
HSV, VZV, CMV
Acyclovir resistant strains of HSV
Side effects of Foscarnet
Nephrotoxicity
Hypocalcemia
-tremors and seizures
Zidovudine MOA
(NRTI)
phosphorylated to a triphosphate that can inhibit reverse transcriptase to cause chain termination
Side effects of Zidovudine
Hematoxicity
Side effects of Didanosine
Pancreatitis
Lamivudine
Least toxic of the NRTIs
Protease Inhibitors MOA
(avirs)
Aspartate protease that cleaves precursor polypeptides in HIV buds to form the proteins of the mature virus core
Side effects of Indinavir
Protease Inhibitor

Crystalluria
Side effect of Ritonavir
Protease Inhibitor

BOOSTS levels of other HIV drugs
-inhibits P450s
Side effects of Protease Inhibitors (avirs)
Insulin resistance
Central adiposity
MOA of Enfuvirtide
Fusion inhibitor

binds gp41
MOA of Maraviroc
Fusion inhibitor

binds CCR5
MOA of Amantadine
Blocks attachment, penetration and uncoating of INFLUENZA A viur
-target is the M2 protein w/in the membrane
Clinical use of Amantadine
Many prophylaxis of
influenza A

Parkinsonism (causes the release of DA from pre-synpatic nerve)
Side effects of Amantadine
Livedo reticularis
MOA of Zanamivir and Oseltamivir
Inhibits neuraminidases of influenza A and B
Clinical uses of Zanamivir and Ostelamivir
Prophylaxis mainly of Influenza A and B
MOA of Ribavirin
Prodrug

Triphosphate inhibits viral RNA polymerase
Clinical use of Ribavirin
Adjunct to alpha-interferons in hepatitis C

Management of RSV